Search for novel Plasmodium falciparum PfATP4 inhibitors from the MMV Pandemic Response Box through a virtual screening approach

References

• Agrawal, P., Kumari, S., Sharma, U., & Sahal, D. (2021). Glideosomal GAP50 binders that inhibit invasion and restrict malaria parasite in vitro and in vivo. https://www.researchsquare.com/article/rs-1099040/latest.pdf
   Google Scholar
• Aier, I., Varadwaj, P. K., & Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific reports, 6(1), 34984. https://doi.org/10.1038/srep34984
   PubMed Web of Science ®Google Scholar
• Andreu Vieyra, C. V., & Berenson, J. R. (2014). The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma. Therapeutic Advances in Hematology, 5(6), 197–210. https://doi.org/10.1177/2040620714552614
   PubMedGoogle Scholar
• Ashton, T. D., Devine, S. M., Möhrle, J. J., Laleu, B., Burrows, J. N., Charman, S. A., Creek, D. J., & Sleebs, B. E. (2019). The development process for discovery and clinical advancement of modern antimalarials. Journal of Medicinal Chemistry, 62(23), 10526–10562. https://doi.org/10.1021/acs.jmedchem.9b00761
   PubMed Web of Science ®Google Scholar
• Barnes, C., Dans, M. G., Jonsdottir, T. K., Crabb, B. S., & Gilson, P. R. (2022). PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion. Frontiers in Cellular and Infection Microbiology, 12, 1060202. https://doi.org/10.3389/fcimb.2022.1060202
   PubMed Web of Science ®Google Scholar
• Bahar, I., Atilgan, A. R., Demirel, M. C., & Erman, B. (1998). Vibrational dynamics of folded proteins: Significance of slow and fast motions in relation to function and stability. Physical Review Letters, 80(12), 2733–2736. https://doi.org/10.1103/PhysRevLett.80.2733
   Web of Science ®Google Scholar
• Bairoch, A., Apweiler, R., Wu, C. H., Barker, W. C., Boeckmann, B., Ferro, S., Gasteiger, E., Huang, H., Lopez, R., Magrane, M., Martin, M. J., Natale, D. A., O’Donovan, C., Redaschi, N., & Yeh, L.-S L. (2005). The universal protein resource (UniProt). Nucleic Acids Research, 33(Database issue), D154–D159. https://doi.org/10.1093/nar/gki070
   PubMed Web of Science ®Google Scholar
• Bakovic, A., Risner, K., Bhalla, N., Alem, F., Chang, T. L., Weston, W., Harness, J. A., & Narayanan, A. (2020). Brilacidin, a COVID-19 drug candidate, exhibits potent in vitro antiviral activity against SARS-CoV-2. BioRxiv, 2020.10.29.352450. https://doi.org/10.1101/2020.10.29.352450
   Google Scholar
• Bathurst, I., & Hentschel, C. (2006). Medicines for Malaria Venture: Sustaining antimalarial drug development. Trends in Parasitology, 22(7), 301–307. https://doi.org/10.1016/J.PT.2006.05.011
   PubMed Web of Science ®Google Scholar
• Biovia, D. S. (2017). BIOVIA discovery studio visualizer. Softw. version, 20, 779.
   Google Scholar
• Borhani, D. W., & Shaw, D. E. (2012). The future of molecular dynamics simulations in drug discovery. Journal of Computer-Aided Molecular Design, 26(1), 15–26. https://doi.org/10.1007/s10822-011-9517-y
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., Salmon, J. K., Shan, Y., & Shaw, D. E. (2006, November 11–17). Scalable algorithms for molecular dynamics simulations on commodity clusters [Paper presentation]. In Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), Tampa, FL. https://doi.org/10.1145/1188455.1188544
   Google Scholar
• Cowman, A. F., Healer, J., Marapana, D., & Marsh, K. (2016). Malaria: Biology and disease. Cell, 167(3), 610–624. https://doi.org/10.1016/J.CELL.2016.07.055
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2002). Pymol: An open-source molecular graphics tool. Advances in Biological Chemistry, 8(4).
   Google Scholar
• Duffy, S., Sykes, M. L., Jones, A. J., Shelper, T. B., Simpson, M., Lang, R., Poulsen, S. A., Sleebs, B. E., & Avery, V. M. (2017). Screening the medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery. Antimicrobial Agents and Chemotherapy, 61(9), e00379-17. https://doi.org/10.1128/AAC.00379-17
   PubMed Web of Science ®Google Scholar
• Ellsworth, M., & Ostrosky-Zeichner, L. (2020). Isavuconazole: Mechanism of action, clinical efficacy, and resistance. Journal of Fungi, 6(4), 324. https://doi.org/10.3390/jof6040324
   Web of Science ®Google Scholar
• Engel, J. A., Jones, A. J., Avery, V. M., Sumanadasa, S. D. M., Ng, S. S., Fairlie, D. P., Adams, T. S., & Andrews, K. T. (2015). Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites. International Journal for Parasitology, 5(3), 117–126. https://doi.org/10.1016/J.IJPDDR.2015.05.004
   Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Gamo, F. J. (2014). Antimalarial drug resistance: New treatments options for Plasmodium. Drug Discovery Today, 11(1), 81–88. https://doi.org/10.1021/jm030644s
   Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. https://doi.org/10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (2009). Identifying and characterizing binding sites and assessing druggability. Journal of Chemical Information and Modeling, 49(2), 377–389. https://doi.org/10.1021/ci800324m
   PubMed Web of Science ®Google Scholar
• Hospital, A., Goñi, J. R., Orozco, M., & Gelpí, J. L. (2015). Molecular dynamics simulations: Advances and applications. Advances and Applications in Bioinformatics and Chemistry, 8(1), 37–47. https://doi.org/10.2147/AABC.S70333
   Google Scholar
• Hu, Y., Jo, H., DeGrado, W. F., & Wang, J. (2022). Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell. Journal of Medical Virology, 94(5), 2188–2200. https://doi.org/10.1002/JMV.27616
   PubMed Web of Science ®Google Scholar
• Jacobson, M. P., Friesner, R. A., Xiang, Z., & Honig, B. (2002). On the role of crystal packing forces in determining protein sidechain conformations. Journal of Molecular Biology, 320(3), 597–608. https://doi.org/10.1016/S0022-2836(02)00470-9
   PubMed Web of Science ®Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins, 55(2), 351–367. https://doi.org/10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Jairajpuri, D. S., Mohammad, T., Adhikari, K., Gupta, P., Hasan, G. M., Alajmi, M. F., Rehman, M. T., Hussain, A., & Hassan, M. I. (2020). Identification of sphingosine kinase-1 inhibitors from bioactive natural products targeting cancer therapy. ACS Omega, 5(24), 14720–14729. https://doi.org/10.1021/acsomega.0c01511
   PubMed Web of Science ®Google Scholar
• Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2
   PubMed Web of Science ®Google Scholar
• Klepeis, J. L., Lindorff-Larsen, K., Dror, R. O., & Shaw, D. E. (2009). Long-timescale molecular dynamics simulations of protein structure and function. Current Opinion in Structural Biology, 19(2), 120–127. https://doi.org/10.1016/J.SBI.2009.03.004
   PubMed Web of Science ®Google Scholar
• Koshy, C., Parthiban, M., & Sowdhamini, R. (2010). 100 ns molecular dynamics simulations to study intramolecular conformational changes in Bax. Journal of Biomolecular Structure & Dynamics, 28(1), 71–83. https://doi.org/10.1080/07391102.2010.10507344
   PubMed Web of Science ®Google Scholar
• Kowalski, R. P., Romanowski, E. G., Yates, K. A., & Mah, F. S. (2016). An independent evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular anti-infective. Journal of Ocular Pharmacology and Therapeutics, 32(1), 23–27. https://Home.Liebertpub.Com/Jop, https://doi.org/10.1089/JOP.2015.0098
   PubMed Web of Science ®Google Scholar
• Krishna, S., Woodrow, C., Webb, R., Penny, J., Takeyasu, K., Kimura, M., & East, J. M. (2001). Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. The Journal of Biological Chemistry, 276(14), 10782–10787. https://doi.org/10.1074/jbc.M010554200
   PubMed Web of Science ®Google Scholar
• Laubach, J. P., Moreau, P., San-Miguel, J. F., & Richardson, P. G. (2015). Panobinostat for the treatment of multiple myeloma. Clinical Cancer Research, 21(21), 4767–4773. https://doi.org/10.1158/1078-0432.CCR-15-0530/176571/AM/PANOBINOSTAT-FOR-THE-TREATMENT-OF-MULTIPLE
   PubMed Web of Science ®Google Scholar
• Liu, Z., Qian, S., Wang, Y., Yan, Y., & Yang, T. (2021). Schrödinger principal-component analysis: On the duality between principal-component analysis and the Schrödinger equation. Physical Review. E, 104(2-2), 025307. https://doi.org/10.1103/PhysRevE.104.025307
   PubMed Web of Science ®Google Scholar
• Lu, C.,Wu, C.,Ghoreishi, D.,Chen, W.,Wang, L.,Damm, W.,Ross, G. A.,Dahlgren, M. K.,Russell, E.,Von Bargen, C. D.,Abel, R.,Friesner, R. A., &Harder, E. D. (2021). OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. Journal of Chemical Theory and Computation, 17(7), 4291–4300. https://doi.org/10.1021/acs.jctc.1c00302 34096718
   PubMed Web of Science ®Google Scholar
• Martínez, L. (2015). Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS One, 10(3), e0119264. https://doi.org/10.1371/JOURNAL.PONE.0119264
   PubMed Web of Science ®Google Scholar
• McCormack, P. L. (2015). Isavuconazonium: First global approval. Drugs, 75(7), 817–822. https://doi.org/10.1007/s40265-015-0398-6
   PubMed Web of Science ®Google Scholar
• Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602
   PubMed Web of Science ®Google Scholar
• Nand, M., Maiti, P., Joshi, T., Chandra, S., Pande, V., Kuniyal, J. C., & Ramakrishnan, M. A. (2020). Virtual screening of anti-HIV1 compounds against SARS-CoV-2: Machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis. Scientific Reports, 10(1), 1–12. https://doi.org/10.1038/s41598-020-77524-x
   PubMed Web of Science ®Google Scholar
• Nwaka, S., Riopel, L., Ubben, D., & Craft, J. C. (2004). Medicines for Malaria Venture new developments in antimalarials. Travel Medicine and Infectious Disease, 2(3–4), 161–170. https://doi.org/10.1016/J.TMAID.2004.03.002
   PubMedGoogle Scholar
• Patra, A. T., Hingamire, T., Belekar, M. A., Xiong, A., Subramanian, G., Bozdech, Z., Preiser, P., Shanmugam, D., & Chandramohanadas, R. (2020). Whole-cell phenotypic screening of medicines for malaria venture pathogen box identifies specific inhibitors of Plasmodium falciparum late-stage development and egress. Antimicrobial Agents and Chemotherapy, 64(5): e01802-19. https://doi.org/10.1128/AAC.01802-19
   PubMed Web of Science ®Google Scholar
• Qiu, D., Pei, J. V., Rosling, J. E. O., Thathy, V., Li, D., Xue, Y., Tanner, J. D., Penington, J. S., Aw, Y. T. V., Aw, J. Y. H., Xu, G., Tripathi, A. K., Gnadig, N. F., Yeo, T., Fairhurst, K. J., Stokes, B. H., Murithi, J. M., Kümpornsin, K., Hasemer, H., … Lehane, A. M. (2022). A G358S mutation in the Plasmodium falciparum Na + pump PfATP4 confers clinically-relevant resistance to cipargamin. Nature Communications, 2022 13:113(1), 1–18. https://doi.org/10.1038/s41467-022-33403-9
   PubMed Web of Science ®Google Scholar
• Reghunandanan, R., & Chandramohanadas, R. (2022). Chemically induced phenotypes during the blood stage development of Plasmodium falciparum as indicators of the drug mode of action. Frontiers in Drug Discovery, 2, 920850. https://doi.org/10.3389/fddsv.2022.920850
   Google Scholar
• Release, S. (2017). 2: LigPrep. Schrödinger, LLC.
   Google Scholar
• Roos, K., Wu, C., Damm, W., Reboul, M., Stevenson, J. M., Lu, C., Dahlgren, M. K., Mondal, S., Chen, W., Wang, L., Abel, R., Friesner, R. A., & Harder, E. D. (2019). OPLS3e: Extending force field coverage for drug-like small molecules. Journal of Chemical Theory and Computation, 15(3), 1863–1874. https://doi.org/10.1021/ACS.JCTC.8B01026/SUPPL_FILE/CT8B01026_SI_002.ZIP
   PubMed Web of Science ®Google Scholar
• Samby, K., Besson, D., Dutta, A., Patra, B., Doy, A., Glossop, P., Mills, J., Whitlock, G., Hooft Van Huijsduijnen, R., Monaco, A., Bilbe, G., Mowbray, C., Perry, B., Adam, A., Wells, T. N. C., & Willis, P. A. (2022). The Pandemic Response Box-accelerating drug discovery efforts after disease outbreaks. ACS Infectious Diseases, 8(4), 713–720. https://doi.org/10.1021/ACSINFECDIS.1C00527/SUPPL_FILE/ID1C00527_SI_002.XLSX
   PubMed Web of Science ®Google Scholar
• Schmitz, K. S., Lange, M. V., Gommers, L., Handrejk, K., Porter, D. P., Alabi, C. A., … de Swart, R. L. (2022). Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds. Viruses, 14(6), 1186. https://doi.org/10.3390/v14061186
   PubMed Web of Science ®Google Scholar
• Sinha, S., Medhi, B., & Sehgal, R. (2014). Challenges of drug-resistant malaria. Parasite, 21, 61. https://doi.org/10.1051/parasite/2014059
   PubMed Web of Science ®Google Scholar
• Spillman, N. J., & Kirk, K. (2015). The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs. International Journal for Parasitology. Drugs and Drug Resistance, 5(3), 149–162. https://doi.org/10.1016/J.IJPDDR.2015.07.001
   PubMed Web of Science ®Google Scholar
• St. Laurent, B., Miller, B., Burton, T. A., Amaratunga, C., Men, S., Sovannaroth, S., Fay, M. P., Miotto, O., Gwadz, R. W., Anderson, J. M., & Fairhurst, R. M. (2015). Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa. Nature Communications, 6(1), 1–7. https://doi.org/10.1038/ncomms9614
   Google Scholar
• Subramanian, G., Belekar, M. A., Shukla, A., Tong, J. X., Sinha, A., Chu, T. T. T., Kulkarni, A. S., Preiser, P. R., Reddy, D. S., Tan, K. S. W., Shanmugam, D., & Chandramohanadas, R. (2018). Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for Malaria Venture Malaria Box molecules. mSphere, 3(1), e00534-17. https://doi.org/10.1128/mSphere.00534-17
   PubMedGoogle Scholar
• Tuteja, R. (2007). Malaria – An overview. The FEBS Journal, 274(18), 4670–4679. https://doi.org/10.1111/J.1742-4658.2007.05997.X
   PubMed Web of Science ®Google Scholar
• Wickham, H. (2011). ggplot2. Wiley interdisciplinary reviews: Computational statistics. Wiley Interdisciplinary Reviews, 3(2), 180–185. https://doi.org/10.1002/wics.147
   Google Scholar
• Wilson, D. T., Dimondi, V. P., Johnson, S. W., Jones, T. M., & Drew, R. H. (2016). Role of isavuconazole in the treatment of invasive fungal infections. Therapeutics and Clinical Risk Management, 12, 1197–1206. https://doi.org/10.2147/TCRM.S90335
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2022). World malaria report 2022. WHO.
   Google Scholar
• Xu, C., Wang, A., Honnen, W., Pinter, A., Weston, W. K., Harness, J. A., Narayanan, A., & Chang, T. L. (2022). Brilacidin, a non-peptide defensin-mimetic molecule, inhibits SARS-CoV-2 infection by blocking viral entry. EC Microbiology, 18(4), 1–4.
   PubMedGoogle Scholar
• Zagórska, A., & Jaromin, A. (2023). Antimalarials targeting the malaria parasite cation ATPase P. falciparum ATP4 (PfATP4). Current Topics in Medicinal Chemistry, 23(3), 214–226. https://doi.org/10.2174/1568026623666221121154354
   PubMed Web of Science ®Google Scholar
• Zhi, C.,Long, Z.-Y.,Manikowski, A.,Comstock, J.,Xu, W.-C.,Brown, N. C.,Tarantino, P. M.,Holm, K. A.,Dix, E. J.,Wright, G. E.,Barnes, M. H.,Butler, M. M.,Foster, K. A.,LaMarr, W. A.,Bachand, B.,Bethell, R.,Cadilhac, C.,Charron, S.,Lamothe, S.,Motorina, I., &Storer, R. (2006). Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors. Journal of Medicinal Chemistry, 49(4), 1455–1465. https://doi.org/10.1021/jm0510023 16480282
   PubMed Web of Science ®Google Scholar